These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 38009775)

  • 21. Characteristics of liver cancer stem cells and clinical correlations.
    Cheng Z; Li X; Ding J
    Cancer Lett; 2016 Sep; 379(2):230-8. PubMed ID: 26272183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of liver cancer stem cells in hepatocellular carcinoma metastasis.
    Niu Q; Ye S; Zhao L; Qian Y; Liu F
    Cancer Biol Ther; 2024 Dec; 25(1):2321768. PubMed ID: 38393655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evolving concept of liver cancer stem cells.
    Nio K; Yamashita T; Kaneko S
    Mol Cancer; 2017 Jan; 16(1):4. PubMed ID: 28137313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic heterogeneity of liver cancer stem cells.
    Kim M; Jo KW; Kim H; Han ME; Oh SO
    Anat Cell Biol; 2023 Mar; 56(1):94-108. PubMed ID: 36384888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133.
    Hur W; Ryu JY; Kim HU; Hong SW; Lee EB; Lee SY; Yoon SK
    Sci Rep; 2017 Apr; 7():45557. PubMed ID: 28367990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoglobin ameliorates the stemness of hepatocellular carcinoma via coupling oxidative-nitrosative stress signals.
    Zhang J; Pei Y; Yang W; Yang W; Chen B; Zhao X; Long S
    Mol Carcinog; 2019 Mar; 58(3):334-343. PubMed ID: 30365183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
    Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
    World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
    Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
    Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Connexin32 regulates expansion of liver cancer stem cells via the PI3K/Akt signaling pathway.
    Li H; Wang B; Qi B; Jiang G; Qin M; Yu M
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35894130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD34(+) Liver Cancer Stem Cells Were Formed by Fusion of Hepatobiliary Stem/Progenitor Cells with Hematopoietic Precursor-Derived Myeloid Intermediates.
    Zeng C; Zhang Y; Park SC; Eun JR; Nguyen NT; Tschudy-Seney B; Jung YJ; Theise ND; Zern MA; Duan Y
    Stem Cells Dev; 2015 Nov; 24(21):2467-78. PubMed ID: 26192559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of cancer stemness maintenance in human liver cancer.
    Liang N; Yang T; Huang Q; Yu P; Liu C; Chen L; Wang Q; Wang G; He X
    Cell Death Dis; 2022 Apr; 13(4):394. PubMed ID: 35449193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Turning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives.
    Chan LH; Luk ST; Ma S
    Mol Cells; 2015 Mar; 38(3):202-9. PubMed ID: 25666349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy.
    Xiao Y; Lin M; Jiang X; Ye J; Guo T; Shi Y; Bian X
    Anal Cell Pathol (Amst); 2017; 2017():5108653. PubMed ID: 28819584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Research Progress in the Therapeutic Strategy Based on Targeting at 
Lung Cancer Stem Cell].
    Lai H; Lin F; Chen N; Wen S; Hu X; Liu L
    Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):57-62. PubMed ID: 29357974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK.
    Zhai B; Zhang X; Sun B; Cao L; Zhao L; Li J; Ge N; Chen L; Qian H; Yin Z
    Tumour Biol; 2016 Jun; 37(6):8047-55. PubMed ID: 26711788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling.
    Ren KQ; Cao XZ; Liu ZH; Guo H; Quan MF; Liu F; Jiang L; Xiang HL; Deng XY; Cao JG
    Int J Oncol; 2013 Nov; 43(5):1719-29. PubMed ID: 23970349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The power and the promise of liver cancer stem cell markers.
    Liu LL; Fu D; Ma Y; Shen XZ
    Stem Cells Dev; 2011 Dec; 20(12):2023-30. PubMed ID: 21651381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer stem cells: Recent insights and therapies.
    Zhou H; Tan L; Liu B; Guan XY
    Biochem Pharmacol; 2023 Mar; 209():115441. PubMed ID: 36720355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KCNN4 Promotes the Stemness Potentials of Liver Cancer Stem Cells by Enhancing Glucose Metabolism.
    Fan J; Tian R; Yang X; Wang H; Shi Y; Fan X; Zhang J; Chen Y; Zhang K; Chen Z; Li L
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-level shear stress induces differentiation of liver cancer stem cells via the Wnt/β-catenin signalling pathway.
    Sun J; Luo Q; Liu L; Song G
    Exp Cell Res; 2019 Feb; 375(1):90-96. PubMed ID: 30599139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.